This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Hearttransplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant risk factors for arrhythmias post-HT.
Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, hearttransplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.
Cardiac arrhythmias are often encountered in orthotopic hearttransplantation (OHT) recipients due to multiple risk factors and may lead to the necessity of permanent pacemaker implantation(PPI). Ischemic time > 4 hours has been associated with graft dysfunction.
Patients after orthotopic hearttransplantation (OHT) are at risk of developing cardiac rhythm disturbances. 1 A rare but significant issue in post-OHT patients is ventricular arrhythmias, in extreme cases leading to cardiac arrest and implantation of an implantable cardioverter-defibrillator (ICD) for secondary prevention.
This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.
Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or hearttransplantation (HTx) in patients with end-stage heart failure (HF).
Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post hearttransplant. Case A 47-year-old male presented with atrial tachycardia 6 months post hearttransplant.
The most common MAE was arrhythmia, representing 46% of MAE, followed by cardiac arrest and bleeding each 20%. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with hearttransplant who had EMB were compared to those without hearttransplant who did not have EMB p=0.001.
Abstract Introduction Cavo-tricuspid isthmus (CTI) dependent atrial flutter (AFL) is one of the most common atrial arrhythmias involving the right atrium (RA) for which radiofrequency catheter ablation has been widely used as a therapy of choice. However, there is limited data on the effect of this intervention on cardiac size and function.
The primary outcome was all-cause death and hearttransplantation. Secondary heart failure (HF) and arrhythmic outcomes were also included. Methods and results Baseline and follow-up data of first-degree relatives of probands affected by DCM/NDLVC were collected. A total of 492 first degree relatives were enrolled.
Cardiomyopathy Cardiomyopathy is a condition that affects the heart muscle, causing it to become enlarged, thick, or rigid. This condition often leads to heart failure, as the heart cannot effectively pump blood. Left Ventricular Assist Device (LVAD) , a mechanical pump that helps the heart pump blood more effectively.
Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.
heart failure/hearttransplant programs that contributed to the study. Dilated cardiomyopathy can be a silent killer DCM is a condition in which the heart muscle weakens and the left ventricle enlarges. Eventually heart failure may develop, which is late-phase disease.
Those with right ventricular and biventricular phenotypes had significantly higher incidence of life threatening arrhythmias compared to the left ventricular phenotype of arrhythmogenic cardiomyopathy. Those with PKP2 mutations had reduced life threatening arrhythmia free survival and higher arrhythmic risk than DSP group.
Free full text: [link] There are 6 categories of criteria : 1) Imaging 2) Pathologic 3) ECG Repolarization 4) ECG Depolarization 5) Arrhythmias 6) Family History. J Electrocardiol, 42 (2009), pp. Of Note: This patient was hemodynamically stable without palpitations at the time ECG #1 was recorded.
months, no deaths, left ventricular failure, malignant arrhythmias, tumor recurrence were observed in the other patients.Conclusion:Our modified ventricular reconstruction procedure has proven successful. During a median follow-up period of 17.4
LV global longitudinal strain did not add diagnostic value but was prognostic for composite end points of death, hearttransplantation, or ventricular arrhythmia (log-rankP=0.04).CONCLUSIONS:In
Background:Variants in theDMDgene, that encodes the cytoskeletal protein, dystrophin, cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart failure, hearttransplantation, and ventricular arrhythmias.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content